Literature DB >> 16718838

Modern management of rectal cancer: a 2006 update.

Glen-C Balch1, Alex De Meo, Jose-G Guillem.   

Abstract

The goal of this review is to outline some of the important surgical issues surrounding the management of patients with early (T1/T2 and N0), as well as locally advanced (T3/T4 and/or N1) rectal cancer. Surgery for rectal cancer continues to develop towards the ultimate goals of improved local control and overall survival, maintaining quality of life, and preserving sphincter, genitourinary, and sexual function. Information concerning the depth of tumor penetration through the rectal wall, lymph node involvement, and presence of distant metastatic disease is of crucial importance when planning a curative rectal cancer resection. Preoperative staging is used to determine the indication for neoadjuvant therapy as well as the indication for local excision versus radical cancer resection. Local excision is likely to be curative in most patients with a primary tumor which is limited to the submucosa (T1N0M0), without high-risk features and in the absence of metastatic disease. In appropriate patients, minimally invasive procedures, such as local excision, TEM, and laparoscopic resection allow for improved patient comfort, shorter hospital stays, and earlier return to preoperative activity level. Once the tumor invades the muscularis propria (T2), radical rectal resection in acceptable operative candidates is recommended. In patients with transmural and/or node positive disease (T3/T4 and/or N1) with no distant metastases, preoperative chemoradiation followed by radical resection according to the principles of TME has become widely accepted. During the planning and conduct of a radical operation for a locally advanced rectal cancer, a number of surgical management issues are considered, including: (1) total mesorectal excision (TME); (2) autonomic nerve preservation (ANP); (3) circumferential resection margin (CRM); (4) distal resection margin; (5) sphincter preservation and options for restoration of bowel continuity; (6) laparoscopic approaches; and (7) postoperative quality of life.

Entities:  

Mesh:

Year:  2006        PMID: 16718838      PMCID: PMC4087961          DOI: 10.3748/wjg.v12.i20.3186

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  88 in total

Review 1.  Ultra-low anterior resection and coloanal pouch reconstruction for carcinoma of the distal rectum.

Authors:  J G Guillem
Journal:  World J Surg       Date:  1997-09       Impact factor: 3.352

2.  Quality of life after anterior resection versus abdominoperineal extirpation for rectal cancer.

Authors:  P Jess; J Christiansen; P Bech
Journal:  Scand J Gastroenterol       Date:  2002-10       Impact factor: 2.423

3.  Local recurrence after mesorectal excision for rectal cancer.

Authors:  A Nesbakken; K Nygaard; O Westerheim; T Mala; O C Lunde
Journal:  Eur J Surg Oncol       Date:  2002-03       Impact factor: 4.424

4.  Local excision of T2 and T3 rectal cancers after downstaging chemoradiation.

Authors:  C J Kim; T J Yeatman; D Coppola; A Trotti; B Williams; J S Barthel; W Dinwoodie; R C Karl; J Marcet
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

5.  Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer.

Authors:  Jose G Guillem; David B Chessin; Alfred M Cohen; Jinru Shia; Madhu Mazumdar; Warren Enker; Philip B Paty; Martin R Weiser; David Klimstra; Leonard Saltz; Bruce D Minsky; W Douglas Wong
Journal:  Ann Surg       Date:  2005-05       Impact factor: 12.969

6.  Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial.

Authors:  J F Bosset; V Magnin; P Maingon; G Mantion; E P Pelissier; M Mercier; G Chaillard; J C Horiot
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

7.  Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer.

Authors:  Salvatore Pucciarelli; Carlo Capirci; Urso Emanuele; Paola Toppan; Maria Luisa Friso; Gian Maria Pennelli; Giovanni Crepaldi; Lara Pasetto; Donato Nitti; Mario Lise
Journal:  Ann Surg Oncol       Date:  2005-02-04       Impact factor: 5.344

8.  How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?

Authors:  Chien-Chih Chen; Rheun-Chuan Lee; Jen-Kou Lin; Ling-Wei Wang; Shung-Haur Yang
Journal:  Dis Colon Rectum       Date:  2005-04       Impact factor: 4.585

9.  Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma.

Authors:  Isabelle Bedrosian; Miguel A Rodriguez-Bigas; Barry Feig; Kelly K Hunt; Lee Ellis; Steven A Curley; Jean Nicolas Vauthey; Marc Delclos; Christopher Crane; Nora Janjan; John M Skibber
Journal:  J Gastrointest Surg       Date:  2004-01       Impact factor: 3.452

10.  Outcome of laparoscopic surgery for rectal cancer in 101 patients.

Authors:  Matthias Anthuber; Alois Fuerst; Florian Elser; Rita Berger; Karl-Walter Jauch
Journal:  Dis Colon Rectum       Date:  2003-08       Impact factor: 4.585

View more
  35 in total

1.  Transanal endoscopic microsurgery for 135 patients with small nonadvanced low rectal cancer (iT1-iT2, iN0): short- and long-term results.

Authors:  Giovanni Lezoche; Mario Guerrieri; Maddalena Baldarelli; Alessandro Maria Paganini; Giancarlo D'Ambrosio; Roberto Campagnacci; Silvia Bartolacci; Emanuele Lezoche
Journal:  Surg Endosc       Date:  2010-10-07       Impact factor: 4.584

2.  3D superhydrophobic electrospun meshes as reinforcement materials for sustained local drug delivery against colorectal cancer cells.

Authors:  Stefan T Yohe; Victoria L M Herrera; Yolonda L Colson; Mark W Grinstaff
Journal:  J Control Release       Date:  2012-06-06       Impact factor: 9.776

Review 3.  Multidisciplinary management in rectal cancer.

Authors:  Asunción Hervás Morón; María Luisa García de Paredes; Eduardo Lobo Martínez
Journal:  Clin Transl Oncol       Date:  2010-12       Impact factor: 3.405

4.  Local treatment for rectal cancer.

Authors:  Daniel P Geisler
Journal:  Clin Colon Rectal Surg       Date:  2007-08

5.  Hospital variation in sphincter preservation for elderly rectal cancer patients.

Authors:  Christopher M Dodgion; Bridget A Neville; Stuart R Lipsitz; Deborah Schrag; Elizabeth Breen; Michael J Zinner; Caprice C Greenberg
Journal:  J Surg Res       Date:  2014-03-22       Impact factor: 2.192

Review 6.  Current status of laparoscopy for the treatment of rectal cancer.

Authors:  Noam Shussman; Steven D Wexner
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

Review 7.  Robotic versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of eight studies.

Authors:  Binghong Xiong; Li Ma; Wei Huang; Qikang Zhao; Yong Cheng; Jingshan Liu
Journal:  J Gastrointest Surg       Date:  2014-11-14       Impact factor: 3.452

8.  Modified simultaneous integrated boost radiotherapy for an unresectable huge refractory pelvic tumor diagnosed as a rectal adenocarcinoma.

Authors:  Takuma Nomiya; Hiroko Akamatsu; Mayumi Harada; Ibuki Ota; Yasuhito Hagiwara; Mayumi Ichikawa; Misako Miwa; Shouhei Kawashiro; Motohisa Hagiwara; Masahiro Chin; Eiji Hashizume; Kenji Nemoto
Journal:  World J Gastroenterol       Date:  2014-12-28       Impact factor: 5.742

9.  Relationships between SMAD3 expression and preoperative fluoropyrimidine-based chemoradiotherapy response in locally advanced rectal cancer patients.

Authors:  Ming-Yii Huang; Chih-Hung Lin; Chun-Ming Huang; Hsiang-Lin Tsai; Ching-Wen Huang; Yung-Sung Yeh; Chee-Yin Chai; Jaw-Yuan Wang
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

10.  Rectal cancer staging.

Authors:  James S Wu
Journal:  Clin Colon Rectal Surg       Date:  2007-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.